Profound Medical (PROF) Other financing activities (2024)
Profound Medical (PROF) posted quarterly Other financing activities of $4.9 million for Q4 2024, up 363.4% quarter-over-quarter from -$1.9 million in Q2 2024.
Profound Medical (PROF) Other financing activities (2024) Analysis & Trends
Profound Medical's Other financing activities history runs 1 years deep, the most recent figure standing at $4.9 million for Q4 2024.
- In Q4 2024, Other financing activities changed N/A year-over-year to $4.9 million; the TTM figure through Dec 2024 stood at $4.9 million (changed N/A YoY), while the FY2025 annual figure was $8000.0, down 99.84% from the prior year.
- Other financing activities for Q4 2024 stood at $4.9 million, up from -$1.9 million in the prior quarter.
- The five-year high for Other financing activities was $4.9 million in Q4 2024, with the low at -$1.9 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Profound Medical | 241.00 Mn | 202.73 Mn | 1.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 4.89 Mn |
| Dec 31, 2024 | 4.89 Mn |
| Jun 30, 2024 | -1.86 Mn |
| Jun 30, 2024 | -1.86 Mn |
| Mar 31, 2024 | 1.86 Mn |
| Mar 31, 2024 | 1.86 Mn |